TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹20 Cr | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
What is the latest Cash Flow from Financing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹0.80 Cr |
How is Cash Flow from Financing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 79.51 | |
| Mar2024 | ₹11 Cr | -73.97 | |
| Mar2023 | ₹42 Cr | 5,172.19 | |
| Mar2022 | ₹0.80 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹292.4 Cr | 2% | -11.9% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 2% |
-11.9% |
-9.3% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses